In ALL, the majority of patients exhibit constitutive initiation of the traditional NF-κB pathway via RelA/p50 complexes, which are essential for enhancing the lifespan of ALL cells by preventing apoptosis or encouraging the proliferation of cells [78,129]. The gene discussed is NFKB1; the disease is acute lymphoblastic leukemia.